Partially agree with the exception that there was no hype in the sense of people buying the stock. There were some that had pushed a narrative that was far fetched like some idiot on another site that was pushing the RGBP was going to fly like KBIO. But for a stock with a float of almost 100 million shares, yesterday's volume showed that there was very little interest. It didn't even trade a million shares. That's was a bad sign. The stock is dead until it can show that HemaXellerate actually works, imo. At that point a BP might step in if interested. But the message board hype that existed prior to this proves that those pushing it have no idea what they are talking about. I'll still sit on the sidelines because the odds are that this moves down, not up.